本页面由Tiger Trade Technology Pte. Ltd.提供服务

再鼎医药

24.59
-0.4000-1.60%
盘后:24.590.00000.00%19:38 EDT
成交量:52.45万
成交额:1,299.28万
市值:27.63亿
市盈率:-14.44
高:25.00
开:24.88
低:24.51
收:24.99
52周最高:32.76
52周最低:15.96
股本:1.12亿
流通股本:9,711.04万
量比:0.61
换手率:0.54%
股息:- -
股息率:- -
每股收益(TTM):-1.7030
每股收益(LYR):-1.6026
净资产收益率:-26.91%
总资产收益率:-14.75%
市净率:4.55
市盈率(LYR):-15.34

数据加载中...

2024/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/19

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/18

重要事件披露

Form 8-K - Current report
2024/06/11

重要事件披露

Form 8-K - Current report
2024/06/06

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities